Fellow of the Academy, Member of the WAMS Executive Council, Member of the Academy Faculty, Member of the Ukrainian Council, Member of the International Medical Research Council, Member of the International Specialty Boards Commission.

Over 30 years of extensive research and administrative experience in the biomedical sciences including:  molecular biology, genetics, immunology, immunohistochemistry, virology, experimental gerontology, oncology, pharmacology, microbiology, physiology, electrophysiology, and stem cell biology; Developed breakthrough technology in human somatic cell reprogramming (U.S. Patents pending), as well as precursor microincubator technology (Use of Xenopus laevis oocytes as microincubators – U.S. Patent  #7,135,336); Held various academic research institute positions including: Department of Veterinary Medicine, University of Illinois, Urbana-Champaign, Illinois; College of Medicine, Bio-Sciences Department and Department of Pharmacology, University of South Florida,  Tampa, Florida.; Department of Pediatrics, Division of Pulmonary Medicine, University of Wisconsin, Madison.; University of Illinois at Chicago, Chicago – MS, Ph.D (Hon) in Biophysics, Bogomolets Institute of Physiology, Kiev, Ukraine; MS in Physics, Biology and Chemistry, Department of Physical Science, Tbilisi State University, Republica of Georgia. He is the Chief Science Officer and founder at Bioquark, Inc., also being a Board Member of RegenerAge SAPI de CV, a clinical company focused on expedited translational therapeutic applications of regenerative and rejuvenative healthcare interventions, and the Reanima Project.

Select Publications:

• Potential Threapeutic Applications of Extract Made from Electroporated Xenopus Laevis frog Oocytes in Murine Models of Melanoma, Traumatic Brain Injury and Experimental Skin Wrinkling – BAOJ Pharm Sci 2016, 2: 22: 024
• Co‐Electroporation with Xenopus Laevis Oocytes Reprograms Normal and Cancerous Human Cells to Resemble Reprogramming Normal and Cancerous Human Cells to Resemble induced Human Pluripotent Stem Cells – BAOJ Cancer Res Ther – 2015, 1: 21: 008
• The alpha7 nicotinic acetylcholine receptor subunit exists in two isoforms that contribute to functional ligand-gated ion channels – Mol Pharmacol. 2004 Sep;66(3):420-9
• Smokeless tobacco-exposed oral keratinocytes increase macromolecular efflux from the in situ oral mucosa – Am J Physiol. 1998 Jan;274(1 Pt 2):R104-11
• Angiotensin-converting enzyme and neutral endopeptidase modulate smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa in vivo – J Lab Clin Med. 1997 Oct;130(4):395-400
• Purified ACE attenuates smokeless tobacco-induced increase in macromolecular efflux from the oral mucosa – J Appl Physiol (1985). 1997 Jul;83(1):74-81
• Aqueous smokeless tobacco extract impairs endothelium-dependent vasodilation in the oral mucosa – J Appl Physiol (1985). 1996 Jul;81(1):225-31
• NMR structure of a receptor-bound G-protein peptide – Nature. 1993 May 20;363(6426):276-81